However, knocking down EpCAM failed to significantly alter radiation responses in Brca1-mutant tumor cells (data not shown), suggesting that, although EpCAM is a functional biomarker candidate, it not a promising target of therapeutics. Here, BRCA1 is linked to neoplasm.